Wyszuk. zaawans.

Tom 16, Nr 4 (2019)
Zaburzenia rytmu serca
Opublikowany online: 2019-11-05

dostęp otwarty

Pokaż PDF Pobierz plik PDF
Wyświetlenia strony 532
Wyświetlenia/pobrania artykułu 787
Pobierz cytowanie

Eksport do Mediów Społecznościowych

Eksport do Mediów Społecznościowych

Podsumowanie wskazań do implantacji układów stymulujących serce

Roman Załuska1, Marcin Bobruk23, Marcin Bobruk45, Marcin Grabowski6, Marcin Bobruk78
DOI: 10.5603/ChSiN.2019.0041
Choroby Serca i Naczyń 2019;16(4):248-256.

Streszczenie

Nieprzerwany rozwój gamy dostępnych urządzeń do stałej stymulacji serca wymaga coraz precyzyjniejszej diagnostyki na etapie doboru właściwej metody stymulacji zależnie od schorzenia, objawów, skuteczności i ryzyka powikłań. Autorzy dokonują przeglądu obecnego stanu literatury oraz zalecań dla szczególnych grup pacjentów. W kontekście przedstawionych wyników i własnych doświadczeń autorzy wskazują mikrostymulatory jako urządzenia, które mogą być przyszłością stałej stymulacji serca.

Słowa kluczowe: stymulacja mięśnia sercowegobradyarytmiabradykardiaomdleniamechanizm kardiodepresyjny

Artykuł dostępny w formacie PDF

Pokaż PDF Pobierz plik PDF

Referencje

  1. Brignole M, Moya A, de Lange FJ, et al. Grupa Robocza Europejskiego Towarzystwa Kardiologicznego (ESC) ds. rozpoznawania i leczenia omdleń. Wytyczne ESC dotyczące rozpoznawania i leczenia omdleń (2018). Kardiol Pol. 2018; 76(8): 1119–1198.
    CrossRefPubMed
  2. Sarasin FP, Hanusa BH, Perneger T, et al. A risk score to predict arrhythmias in patients with unexplained syncope. Acad Emerg Med. 2003; 10(12): 1312–1317.
    CrossRefPubMed
  3. Quinn J, McDermott D, Stiell I, et al. Prospective validation of the San Francisco Syncope Rule to predict patients with serious outcomes. Ann Emerg Med. 2006; 47(5): 448–454.
    CrossRefPubMed
  4. Middlekauff HR, Stevenson WG, Stevenson LW, et al. Syncope in advanced heart failure: high risk of sudden death regardless of origin of syncope. J Am Coll Cardiol. 1993; 21(1): 110–116.
    CrossRefPubMed
  5. Brembilla-Perrot B, Suty-Selton C, Beurrier D, et al. Differences in mechanisms and outcomes of syncope in patients with coronary disease or idiopathic left ventricular dysfunction as assessed by electrophysiologic testing. J Am Coll Cardiol. 2004; 44(3): 594–601.
    CrossRefPubMed
  6. Steinberg JS, Beckman K, Greene HL, et al. Follow-up of patients with unexplained syncope and inducible ventricular tachyarrhythmias: analysis of the AVID registry and an AVID substudy. Antiarrhythmics Versus Implantable Defibrillators. J Cardiovasc Electrophysiol. 2001; 12(9): 996–1001.
    CrossRefPubMed
  7. Pezawas T, Stix G, Kastner J, et al. Unexplained syncope in patients with structural heart disease and no documented ventricular arrhythmias: value of electrophysiologically guided implantable cardioverter defibrillator therapy. Europace. 2003; 5(3): 305–312.
    CrossRefPubMed
  8. Olshansky B, Poole JE, Johnson G, et al. SCD-HeFT Investigators. Syncope predicts the outcome of cardiomyopathy patients: analysis of the SCD-HeFT study. J Am Coll Cardiol. 2008; 51(13): 1277–1282.
    CrossRefPubMed
  9. Goldberger JJ, Cain ME, Hohnloser SH, et al. American Heart Association, American College of Cardiology Foundation, Heart Rhythm Society. American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death. A scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention. J Am Coll Cardiol. 2008; 52(14): 1179–1199.
    CrossRefPubMed
  10. Del Rosso A, Alboni P, Brignole M, et al. Relation of clinical presentation of syncope to the age of patients. Am J Cardiol. 2005; 96(10): 1431–1435.
    CrossRefPubMed
  11. Martin TP, Hanusa BH, Kapoor WN. Risk stratification of patients with syncope. Ann Emerg Med. 1997; 29(4): 459–466.
    CrossRefPubMed
  12. Colivicchi F, Ammirati F, Melina D, et al. OESIL (Osservatorio Epidemiologico sulla Sincope nel Lazio) Study Investigators. Development and prospective validation of a risk stratification system for patients with syncope in the emergency department: the OESIL risk score. Eur Heart J. 2003; 24(9): 811–819.
    CrossRefPubMed
  13. Del Rosso A, Ungar A, Maggi R, et al. Clinical predictors of cardiac syncope at initial evaluation in patients referred urgently to a general hospital: the EGSYS score. Heart. 2008; 94(12): 1620–1626.
    CrossRefPubMed
  14. Mittal S, Hao SC, Iwai S, et al. Significance of inducible ventricular fibrillation in patients with coronary artery disease and unexplained syncope. J Am Coll Cardiol. 2001; 38(2): 371–376.
    CrossRefPubMed
  15. Del Rosso A, Alboni P, Brignole M, et al. Diagnostic value of history in patients with syncope with or without heart disease. J Am Coll Cardiol. 2001; 37(7): 1921–1928.
    CrossRefPubMed
  16. Berecki-Gisolf J, Sheldon A, Wieling W, et al. Identifying cardiac syncope based on clinical history: a literature-based model tested in four independent datasets. PLoS One. 2013; 8(9): e75255.
    CrossRefPubMed
  17. Locati ET, Moya A, Oliveira M, et al. External prolonged electrocardiogram monitoring in unexplained syncope and palpitations: results of the SYNARR-Flash study. Europace. 2016; 18(8): 1265–1272.
    CrossRefPubMed
  18. Linzer M, Pritchett EL, Pontinen M, et al. Incremental diagnostic yield of loop electrocardiographic recorders in unexplained syncope. Am J Cardiol. 1990; 66(2): 214–219.
    CrossRefPubMed
  19. Schuchert A, Maas R, Kretzschmar C, et al. Diagnostic yield of external electrocardiographic loop recorders in patients with recurrent syncope and negative tilt table test. Pacing Clin Electrophysiol. 2003; 26(9): 1837–1840.
    CrossRefPubMed
  20. Da Costa A, Defaye P, Romeyer-Bouchard C, et al. Clinical impact of the implantable loop recorder in patients with isolated syncope, bundle branch block and negative workup: a randomized multicentre prospective study. Arch Cardiovasc Dis. 2013; 106(3): 146–154.
    CrossRefPubMed
  21. Brignole M, Menozzi C, Moya A, et al. International Study on Syncope of Uncertain Etiology (ISSUE) Investigators. Mechanism of syncope in patients with bundle branch block and negative electrophysiological test. Circulation. 2001; 104(17): 2045–2050.
    CrossRefPubMed
  22. Moya A, García-Civera R, Croci F, et al. Bradycardia detection in Bundle Branch Block (B4) study. Diagnosis, management, and outcomes of patients with syncope and bundle branch block. Eur Heart J. 2011; 32(12): 1535–1541.
    CrossRefPubMed
  23. Zaidi A, Clough P, Cooper P, et al. Misdiagnosis of epilepsy: many seizure-like attacks have a cardiovascular cause. J Am Coll Cardiol. 2000; 36(1): 181–184.
    CrossRefPubMed
  24. Ho RT, Wicks T, Wyeth D, et al. Generalized tonic-clonic seizures detected by implantable loop recorder devices: diagnosing more than cardiac arrhythmias. Heart Rhythm. 2006; 3(7): 857–861.
    CrossRefPubMed
  25. Petkar S, Hamid T, Iddon P, et al. Prolonged implantable electrocardiographic monitoring indicates a high rate of misdiagnosis of epilepsy--REVISE study. Europace. 2012; 14(11): 1653–1660.
    CrossRefPubMed
  26. Maggi R, Rafanelli M, Ceccofiglio A, et al. Additional diagnostic value of implantable loop recorder in patients with initial diagnosis of real or apparent transient loss of consciousness of uncertain origin. Europace. 2014; 16(8): 1226–1230.
    CrossRefPubMed
  27. Farwell DJ, Freemantle N, Sulke N, et al. Use of implantable loop recorders in the diagnosis and management of syncope. Eur Heart J. 2004; 25(14): 1257–1263.
    CrossRefPubMed
  28. Krahn AD, Klein GJ, Yee R, et al. Randomized assessment of syncope trial: conventional diagnostic testing versus a prolonged monitoring strategy. Circulation. 2001; 104(1): 46–51.
    CrossRefPubMed
  29. Edvardsson N, Garutti C, Rieger G, et al. PICTURE Study Investigators. Unexplained syncope: implications of age and gender on patient characteristics and evaluation, the diagnostic yield of an implantable loop recorder, and the subsequent treatment. Clin Cardiol. 2014; 37(10): 618–625.
    CrossRefPubMed
  30. Edvardsson N, Wolff C, Tsintzos S, et al. Costs of unstructured investigation of unexplained syncope: insights from a micro-costing analysis of the observational PICTURE registry. Europace. 2015; 17(7): 1141–1148.
    CrossRefPubMed
  31. Drak-Hernández Y, Toquero-Ramos J, Fernández JM, et al. Effectiveness and safety of remote monitoring of patients with an implantable loop recorder. Rev Esp Cardiol (Engl Ed). 2013; 66(12): 943–948.
    CrossRefPubMed
  32. Furukawa T, Maggi R, Bertolone C, et al. Effectiveness of remote monitoring in the management of syncope and palpitations. Europace. 2011; 13(3): 431–437.
    CrossRefPubMed
  33. Rothman SA, Laughlin JC, Seltzer J, et al. The diagnosis of cardiac arrhythmias: a prospective multi-center randomized study comparing mobile cardiac outpatient telemetry versus standard loop event monitoring. J Cardiovasc Electrophysiol. 2007; 18(3): 241–247.
    CrossRefPubMed
  34. Woelfel AK, Simpson RJ, Gettes LS, et al. Exercise-induced distal atrioventricular block. J Am Coll Cardiol. 1983; 2(3): 578–581.
    CrossRefPubMed
  35. Byrne JM, Marais HJ, Cheek GA. Exercise-induced complete heart block in a patient with chronic bifascicular block. J Electrocardiol. 1994; 27(4): 339–342.
    CrossRefPubMed
  36. Aste M, Oddone D, Donateo P, et al. Syncope in patients paced for atrioventricular block. Europace. 2016; 18(11): 1735–1739.
    CrossRefPubMed
  37. Sumiyoshi M, Nakata Y, Yasuda M, et al. Clinical and electrophysiologic features of exercise-induced atrioventricular block. Am Heart J. 1996; 132(6): 1277–1281.
    CrossRefPubMed
  38. Wissocq L, Ennezat PV, Mouquet F. Exercise-induced high-degree atrioventricular block. Arch Cardiovasc Dis. 2009; 102(10): 733–735.
    CrossRefPubMed
  39. McAnulty JH, Rahimtoola SH, Murphy E, et al. Natural history of high-risk bundle-branch block. N Engl J Med. 1982; 307(3): 137–143.
    CrossRefPubMed
  40. Moya A, García-Civera R, Croci F, et al. Bradycardia detection in Bundle Branch Block (B4) study. Diagnosis, management, and outcomes of patients with syncope and bundle branch block. Eur Heart J. 2011; 32(12): 1535–1541.
    CrossRefPubMed
  41. Kalscheur MM, Donateo P, Wenzke KE, et al. Long-term outcome of patients with bifascicular block and unexplained syncope following cardiac pacing. Pacing Clin Electrophysiol. 2016; 39(10): 1126–1131.
    CrossRefPubMed
  42. Krahn AD, Klein GJ, Yee R, et al. The etiology of syncope in patients with negative tilt table and electrophysiological testing. Circulation. 1995; 92(7): 1819–1824.
    CrossRefPubMed
  43. Brignole M, Auricchio A, de Lange FJ, et al. Grupa Robocza Europejskiego Towarzystwa Kardiologicznego (ESC) do spraw stymulacji serca i terapii resynchronizującej we współpracy z European Heart Rhythm Association (EHRA). Wytyczne ESC dotyczące stymulacji serca i terapii resynchronizującej w 2013 roku. Kardiol Pol. 2013; 71(Suppl V): 133–192.
    CrossRef
  44. Olshansky B, Hahn EA, Hartz VL, et al. Clinical significance of syncope in the electrophysiologic study versus electrocardiographic monitoring (ESVEM) trial. The ESVEM Investigators. Am Heart J. 1999; 137(5): 878–886.
    CrossRefPubMed
  45. Moya A, García-Civera R, Croci F, et al. Bradycardia detection in Bundle Branch Block (B4) study. Diagnosis, management, and outcomes of patients with syncope and bundle branch block. Eur Heart J. 2011; 32(12): 1535–1541.
    CrossRefPubMed
  46. Gronda M, Magnani A, Occhetta E, et al. Electrophysiological study of atrio-ventricular block and ventricular conduction defects. Prognostic and therapeutical implications. G Ital Cardiol. 1984; 14(10): 768–773.
    PubMed
  47. Bergfeldt L, Edvardsson N, Rosenqvist M, et al. Atrioventricular block progression in patients with bifascicular block assessed by repeated electrocardiography and a bradycardia-detecting pacemaker. Am J Cardiol. 1994; 74(11): 1129–1132.
    CrossRefPubMed
  48. Kaul U, DEV V, NARULA J, et al. Evaluation of patients with bundle branch block and “unexplained” syncope: a study based on comprehensive electrophysiologic testing and ajmaline stress. Pacing Clin Electrophysiol. 1988; 11(3): 289–297.
    CrossRefPubMed
  49. Kalscheur MM, Donateo P, Wenzke KE, et al. Long-term outcome of patients with bifascicular block and unexplained syncope following cardiac pacing. Pacing Clin Electrophysiol. 2016; 39(10): 1126–1131.
    CrossRefPubMed
  50. Scheinman MM, Peters RW, Suavé MJ, et al. Value of the H-Q interval in patients with bundle branch block and the role of prophylactic permanent pacing. Am J Cardiol. 1982; 50(6): 1316–1322.
    CrossRefPubMed
  51. Dhingra RC. Sinus node dysfunction. Pacing Clin Electrophysiol. 1983; 6(5 Pt 2): 1062–1069.
    CrossRefPubMed
  52. Gann D, Tolentino A, Samet P. Electrophysiologic evaluation of elderly patients with sinus bradycardia: a long-term follow-up study. Ann Intern Med. 1979; 90(1): 24–29.
    CrossRefPubMed
  53. Menozzi C, Brignole M, Alboni P, et al. The natural course of untreated sick sinus syndrome and identification of the variables predictive of unfavorable outcome. Am J Cardiol. 1998; 82(10): 1205–1209.
    CrossRefPubMed
  54. Priori SG, Blomström-Lundqvist C, Mazzanti A, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 2015; 36(41): 2793–2867.
    CrossRefPubMed
  55. Blomström-Lundqvist C, Scheinman MM, Aliot EM, et al. American College of Cardiology, American Heart Association Task Force on Practice Guidelines, European Society of Cardiology Committee for Practice Guidelines. Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias). Circulation. 2003; 108(15): 1871–1909.
    CrossRefPubMed
  56. Alboni P, Menozzi C, Brignole M, et al. Effects of permanent pacemaker and oral theophylline in sick sinus syndrome the THEOPACE study: a randomized controlled trial. Circulation. 1997; 96(1): 260–266.
    CrossRefPubMed
  57. Breivik K, Ohm OJ, Segadal L. Sick sinus syndrome treated with permanent pacemaker in 109 patients. A follow-up study. Acta Med Scand. 1979; 206(3): 153–159.
    CrossRefPubMed
  58. Härtel G, Talvensaari T. Treatment of sinoatrial syndrome with permanent cardiac pacing in 90 patients. Acta Med Scand. 1975; 198(5): 341–347.
    CrossRefPubMed
  59. Rasmussen K. Chronic sinus node disease: natural course and indications for pacing. Eur Heart J. 1981; 2(6): 455–459.
    CrossRefPubMed
  60. Sasaki Y, Shimotori M, Akahane K, et al. Long-term follow-up of patients with sick sinus syndrome: a comparison of clinical aspects among unpaced, ventricular inhibited paced, and physiologically paced groups. Pacing Clin Electrophysiol. 1988; 11(11 Pt 1): 1575–1583.
    CrossRefPubMed
  61. Brignole M, Arabia F, Ammirati F, et al. Syncope Unit Project 2 (SUP 2) investigators. Standardized algorithm for cardiac pacing in older patients affected by severe unpredictable reflex syncope: 3-year insights from the Syncope Unit Project 2 (SUP 2) study. Europace. 2016; 18(9): 1427–1433.
    CrossRefPubMed
  62. Brignole M, Menozzi C. The natural history of carotid sinus syncope and the effect of cardiac pacing. Europace. 2011; 13(4): 462–464.
    CrossRefPubMed
  63. Gaggioli G, Brignole M, Menozzi C, et al. A positive response to head-up tilt testing predicts syncopal recurrence in carotid sinus syndrome patients with permanent pacemakers. Am J Cardiol. 1995; 76(10): 720–722.
    CrossRefPubMed
  64. Deharo JC, Guieu R, Mechulan A, et al. Syncope without prodromes in patients with normal heart and normal electrocardiogram: a distinct entity. J Am Coll Cardiol. 2013; 62(12): 1075–1080.
    CrossRefPubMed
  65. Brignole M, Deharo JC, De Roy L, et al. Syncope due to idiopathic paroxysmal atrioventricular block: long-term follow-up of a distinct form of atrioventricular block. J Am Coll Cardiol. 2011; 58(2): 167–173.
    CrossRefPubMed
  66. Brignole M, Guieu R, Tomaino M, et al. Mechanism of syncope without prodromes with normal heart and normal electrocardiogram. Heart Rhythm. 2017; 14(2): 234–239.
    CrossRefPubMed
  67. Brignole M, Menozzi C, Moya A, et al. International Study on Syncope of Uncertain Etiology 3 (ISSUE-3) Investigators. Pacemaker therapy in patients with neurally mediated syncope and documented asystole: Third International Study on Syncope of Uncertain Etiology (ISSUE-3): a randomized trial. Circulation. 2012; 125(21): 2566–2571.
    CrossRefPubMed
  68. Puggioni E, Guiducci V, Brignole M, et al. Results and complications of the carotid sinus massage performed according to the. Am J Cardiol. 2002; 89(5): 599–601.
    CrossRefPubMed
  69. Sutton R, Brignole M, Menozzi C, et al. Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope : pacemaker versus no therapy: a multicenter randomized study. The Vasovagal Syncope International Study (VASIS) Investigators. Circulation. 2000; 102(3): 294–299.
    CrossRefPubMed
  70. Ammirati F, Colivicchi F, Santini M, et al. Syncope Diagnosis and Treatment Study Investigators. Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope: a multicenter, randomized, controlled trial. Circulation. 2001; 104(1): 52–57.
    CrossRefPubMed
  71. Barón-Esquivias G, Moya-Mitjans A, Martinez-Alday J, et al. Dual-Chamber Pacing With Closed Loop Stimulation in Recurrent Reflex Vasovagal Syncope: The SPAIN Study. J Am Coll Cardiol. 2017; 70(14): 1720–1728.
    CrossRefPubMed
  72. Flammang D, Church TR, De Roy L, et al. ATP Multicenter Study. Treatment of unexplained syncope: a multicenter, randomized trial of cardiac pacing guided by adenosine 5'-triphosphate testing. Circulation. 2012; 125(1): 31–36.
    CrossRefPubMed
  73. Brignole M, Guieu R, Tomaino M, et al. Mechanism of syncope without prodromes with normal heart and normal electrocardiogram. Heart Rhythm. 2017; 14(2): 234–239.
    CrossRefPubMed
  74. Connolly SJ, Sheldon R, Thorpe KE, et al. VPS II Investigators. Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II): a randomized trial. JAMA. 2003; 289(17): 2224–2229.
    CrossRefPubMed
  75. Raviele A, Giada F, Menozzi C, et al. Vasovagal Syncope and Pacing Trial Investigators. A randomized, double-blind, placebo-controlled study of permanent cardiac pacing for the treatment of recurrent tilt-induced vasovagal syncope. The vasovagal syncope and pacing trial (SYNPACE). Eur Heart J. 2004; 25(19): 1741–1748.
    CrossRefPubMed
  76. Behar S, Zissman E, Zion M, et al. Prognostic significance of second-degree atrioventricular block in inferior wall acute myocardial infarction. SPRINT Study Group. Am J Cardiol. 1993; 72(11): 831–834.
    CrossRefPubMed
  77. Col JJ, Weinberg SL. The incidence and mortality of intraventricular conduction defects in acute myocardial infarction. Am J Cardiol. 1972; 29(3): 344–350.
    CrossRefPubMed
  78. Ginks WR, Sutton R, Oh W, et al. Long-term prognosis after acute anterior infarction with atrioventricular block. Br Heart J. 1977; 39(2): 186–189.
    CrossRefPubMed
  79. Jim MH, Chan AOO, Tse HF, et al. Clinical and angiographic findings of complete atrioventricular block in acute inferior myocardial infarction. Ann Acad Med Singapore. 2010; 39(3): 185–190.
    PubMed
  80. Gang UJ, Hvelplund A, Pedersen S, et al. High-degree atrioventricular block complicating ST-segment elevation myocardial infarction in the era of primary percutaneous coronary intervention. Europace. 2012; 14(11): 1639–1645.
    CrossRefPubMed
  81. Chang SuM, Nagueh SF, Spencer WH, et al. Complete heart block: determinants and clinical impact in patients with hypertrophic obstructive cardiomyopathy undergoing nonsurgical septal reduction therapy. J Am Coll Cardiol. 2003; 42(2): 296–300.
    CrossRefPubMed
  82. Topilski I, Sherez J, Keren G, et al. Long-term effects of dual-chamber pacing with periodic echocardiographic evaluation of optimal atrioventricular delay in patients with hypertrophic cardiomyopathy >50 years of age. Am J Cardiol. 2006; 97(12): 1769–1775.
    CrossRefPubMed
  83. Kappenberger LJ, Linde C, Jeanrenaud X, et al. Pacing in hypertrophic obstructive cardiomyopathy. A randomized crossover study. PIC Study Group. Eur Heart J. 1997; 18(8): 1249–1256.
    CrossRefPubMed
  84. Maron BJ, Nishimura RA, McKenna WJ, et al. Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY). Circulation. 1999; 99(22): 2927–2933.
    CrossRefPubMed
  85. Nishimura RA, Trusty JM, Hayes DL, et al. Dual-chamber pacing for hypertrophic cardiomyopathy: a randomized, double-blind, crossover trial. J Am Coll Cardiol. 1997; 29(2): 435–441.
    CrossRefPubMed
  86. Galve E, Sambola A, Saldaña G, et al. Late benefits of dual-chamber pacing in obstructive hypertrophic cardiomyopathy: a 10-year follow-up study. Heart. 2010; 96(5): 352–356.
    CrossRefPubMed
  87. Megevand A, Ingles J, Richmond DR, et al. Long-term follow-up of patients with obstructive hypertrophic cardiomyopathy treated with dual-chamber pacing. Am J Cardiol. 2005; 95(8): 991–993.
    CrossRefPubMed

Informacje o plikach cookie

Niezbędne pliki cookie

Zawsze aktywne

Te pliki cookie są niezbędne do prawidłowego wyświetlania i działania strony internetowej. Zablokowanie ich może spowodować nieprawidłowe działanie strony.

Analityczne pliki cookie

W ramach naszej strony internetowej korzystamy z narzędzi analitycznych, takich jak Google Analytics, które umożliwiają nam weryfikację ruchu na stronie internetowej. Narzędzia te mogą wymagać użycia plików cookie.

Społecznościowe pliki cookie

Są to pliki cookie powiązane z portalami społecznościowymi, z których korzystamy. Zaakceptowanie ich pozwoli na powiązanie Twojej wizyty na stronie z naszymi profilami w mediach społecznościowych.

Marketingowe pliki cookie

Są to pliki cookie odpowiedzialne za prowadzenie działań reklamowych i marketingowych - zgoda na ich wykorzystanie pozwoli nam kierować do Ciebie reklamy, bazujące na podstawie Twoich wcześniejszych aktywności w ramach naszej stronie internetowej.

Choroby Serca i Naczyń

O Via Medica Reklama
Księgarnia (Ikamed) TVMed
Aktualności
Copyright © 2023 Via Medica Regulations Cookie policy Privacy policy Legal Notice